The allure of achieving incredible gains in short time periods has many investors looking to strike it rich picking biotech stocks. But it's also attracted the attention of many fund companies, which are looking to capitalize on the average investor's interest in a more diversified form of biotech exposure. While my personal preference for the longer-term investor looking to invest in biotech is to target a basket of stocks, in the following video, I offer up an opinion on the biotech ETF that best captures the essence of biotech investing.
The Better Way to Play Biotech
By Brenton Flynn – Jan 4, 2013 at 1:35PM
NYSEMKT: XBI
SPDR Series Trust - SPDR S&P Biotech ETF

Market Cap
$0.0M
Today's Change
(0.59%) $0.67
Current Price
$114.68
Price as of November 12, 2025 at 10:09 AM ET
If you're going the ETF route, this product appears to be the best option